AU1393301A - Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use - Google Patents

Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use

Info

Publication number
AU1393301A
AU1393301A AU13933/01A AU1393301A AU1393301A AU 1393301 A AU1393301 A AU 1393301A AU 13933/01 A AU13933/01 A AU 13933/01A AU 1393301 A AU1393301 A AU 1393301A AU 1393301 A AU1393301 A AU 1393301A
Authority
AU
Australia
Prior art keywords
liposomes
peptides
peptide
protein
encapsulating proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13933/01A
Other languages
English (en)
Inventor
Steffen Panzner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOVOSOM GmbH
Original Assignee
NOVOSOM GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOVOSOM GmbH filed Critical NOVOSOM GmbH
Publication of AU1393301A publication Critical patent/AU1393301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU13933/01A 1999-11-09 2000-11-09 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use Abandoned AU1393301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19954843 1999-11-09
DE19954843A DE19954843C2 (de) 1999-11-09 1999-11-09 Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung
PCT/EP2000/011079 WO2001034115A2 (de) 1999-11-09 2000-11-09 Verfahren zur verkapselung von proteinen oder peptiden in liposomen, mit dem verfahren hergestellte liposomen und deren verwendung

Publications (1)

Publication Number Publication Date
AU1393301A true AU1393301A (en) 2001-06-06

Family

ID=7929069

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13933/01A Abandoned AU1393301A (en) 1999-11-09 2000-11-09 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use

Country Status (7)

Country Link
EP (1) EP1227794B1 (https=)
JP (1) JP2003513901A (https=)
AT (1) ATE311175T1 (https=)
AU (1) AU1393301A (https=)
DE (2) DE19954843C2 (https=)
DK (1) DK1227794T3 (https=)
WO (1) WO2001034115A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152145A1 (de) * 2001-10-19 2003-05-22 Novosom Ag Stabilisierung von Liposomen und Emulsionen
EP1585504A4 (en) * 2002-11-06 2009-07-15 Azaya Therapeutics Inc Protein stabilized liposomal formulations of pharmaceutical active ingredients
WO2004100927A2 (de) * 2003-05-12 2004-11-25 Novosom Ag Injizierbare depots aus liposomalen aggregaten zum wirkstoffdelivery
US20090297592A1 (en) * 2005-05-11 2009-12-03 Jcr Pharmaceuticals Co., Ltd. Lipid Vesicle Composition
CN103071209A (zh) 2005-11-17 2013-05-01 周吉尼克斯股份有限公司 用无针注射递送粘稠制剂
US8268347B1 (en) 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
ES2563061T3 (es) 2008-04-28 2016-03-10 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
PL2474306T3 (pl) 2009-08-31 2017-06-30 Nanocarrier Co., Ltd. Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4342826A (en) * 1980-02-04 1982-08-03 Collaborative Research, Inc. Immunoassay products and methods
JPS5782310A (en) * 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation
US4933121A (en) * 1986-12-10 1990-06-12 Ciba Corning Diagnostics Corp. Process for forming liposomes
JPH06271460A (ja) * 1993-03-22 1994-09-27 Nippon Oil & Fats Co Ltd リポソーム分散液の製造方法
JPH0717874A (ja) * 1993-06-18 1995-01-20 Terumo Corp ヘモグロビン内包リポソーム
EP0918539B1 (en) * 1996-02-16 2005-10-19 Biomira Usa Inc. Vaccine for b-cell malignancies
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization

Also Published As

Publication number Publication date
DE19954843C2 (de) 2003-11-20
DE50011769D1 (de) 2006-01-05
WO2001034115A2 (de) 2001-05-17
DE19954843A1 (de) 2001-05-17
EP1227794B1 (de) 2005-11-30
EP1227794A2 (de) 2002-08-07
WO2001034115A3 (de) 2001-09-07
JP2003513901A (ja) 2003-04-15
DK1227794T3 (da) 2006-04-03
ATE311175T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
WO2002018572A3 (en) Membrane penetrating peptides and uses thereof
WO2001078503A3 (en) Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
CA2400295A1 (en) Modified factor viii
WO2001057194A3 (en) Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
EP1304382A3 (en) Production of peptides in plants as viral coat protein fusions
CA2263889A1 (en) P-selectin ligand proteins
ATE219380T1 (de) Vehikel zum einbringen von nukleinsäuren in zellen
DE69730218D1 (de) Fusogene liposomen
ES2145015T3 (es) Proteasas especificas de ubiquitina.
AU2656695A (en) Purified scytalidium laccases and nucleic acids encoding same
AUPP051497A0 (en) Antimicrobial peptides
WO2002083890A3 (en) Use of clya hemolysin for excretion of fusion proteins
DE60036930D1 (de) Humanes cytokin als ligand des zalpha rezeptors und dessen verwendungen
CZ20002008A3 (cs) Hydrofobně modifikované proteinové prostředky a způsoby modifikace
AU1393301A (en) Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use
NZ527971A (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
WO2002012468A3 (en) 2,5-dkg permeases
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
EP1757684A3 (en) A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
WO1999043802A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
ATE294189T1 (de) Kristallisation von proteinen
WO1999064439A3 (en) Methods for increasing cationic antimicrobial peptides
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
IL139272A0 (en) New peptide fragments for protein purification

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 35, PAGE(S) 7527-7530 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 59963/00, 77978/00, 10286/01, 10391/01, 10423/01, 11276/01, 11598/01, 11600/01, 11605/01, 11619/01, 11643/01, 12747/01, 12868/01, 12870/01, 12873/01, 12880/01, 12882/01, 12920/01, 12922/01, 12943/01, 12963/01, 13933/01 AND 17215/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase